Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Global X Management CO LLC CMCO Columbus Mckinnon Corp 13G 6.15% 6mo
Lagoda Investment Management, L.P. STXS Stereotaxis, Inc. 13G/A 4.5% 6mo
MORGAN STANLEY XIFR XPLR Infrastructure, LP 13G 7.1% 6mo
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC NOV NOV Inc. 13G/A 4.14% 6mo
T. Rowe Price Investment Management, Inc. AEE Ameren Corp 13G/A 2.7% 6mo
METEORA CAPITAL, LLC APXT Apex Treasury Corp 13G/A 7.8% 6mo
Pentwater Capital Management LP AMC Amc Entertainment Holdings, Inc. 13G 9.99% 6mo
ARMISTICE CAPITAL, LLC AGIO Agios Pharmaceuticals, Inc. 13G/A 4.57% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ CCC CCC Intelligent Solutions Holdings Inc. 13G 5.5% 6mo
METEORA CAPITAL, LLC RAIN Rain Enhancement Technologies Holdco, Inc. 13G 7.85% 6mo
ORBIMED ADVISORS LLC NPCE NeuroPace Inc 13G/A 6.2% 6mo
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD IIF Morgan Stanley India Investment Fund, Inc. 13G/A 10.1% 6mo
Tangney Jeffrey DOCS Doximity, Inc. 13G/A 29.9% 6mo
Seven Fleet Capital Management LP CTMX CytomX Therapeutics, Inc. 13G/A 0.5% 6mo
Berkshire Hathaway Inc DPZ Dominos Pizza Inc 13G/A 0% 6mo
MSOP GP, L.L.C. CHYM Chime Financial, Inc. 13G/A 2.8% 6mo
Alyeska Investment Group, L.P. MTVA MetaVia Inc. 13G 9.99% 6mo
RIVERNORTH CAPITAL MANAGEMENT, LLC GLO Clough Global Opportunities Fund 13G/A 5.22% 6mo
Bentley Corinne Patricia BSY Bentley Systems Inc 13G/A 13.2% 6mo
Extract Advisors LLC AEC Anfield Energy Inc. 13G/A 6.6% 6mo
BIOTECHNOLOGY VALUE FUND L P CGEM Cullinan Therapeutics, Inc. 13G/A 9.99% 6mo
DARLINGTON PARTNERS CAPITAL MANAGEMENT, LP FOUR Shift4 Payments, Inc. 13G/A 8.3% 6mo
GREAT POINT PARTNERS LLC CNTX Context Therapeutics Inc. 13G/A 2.44% 6mo
Commodore Capital LP ANRO Alto Neuroscience, Inc. 13G/A 9.9% 6mo
Wesley Mendonca Batista PICS PicS N.V. 13G 74.5% 6mo
Hood River Capital Management LLC HCI HCI Group, Inc. 13G/A 4.8% 6mo
Alyeska Investment Group, L.P. MRLN Merlin, Inc. 13G 9.9% 6mo
Northern Right Capital Management, L.P. GECC Great Elm Capital Corp. 13G/A 3.3% 6mo
AQR CAPITAL MANAGEMENT LLC BFAM Bright Horizons Family Solutions Inc. 13G 6.04% 6mo
TCG Crossover GP II, LLC TNGX Tango Therapeutics, Inc. 13G/A 8.1% 6mo
LAZARD ASSET MANAGEMENT LLC MXF Mexico Fund Inc 13G 5% 6mo
EcoR1 Capital, LLC XNCR Xencor Inc 13G/A 2.9% 6mo
TANG CAPITAL MANAGEMENT LLC CBIO Crescent Biopharma, Inc. 13G/A 4.21% 6mo
WELLINGTON MANAGEMENT GROUP LLP PEBK Peoples Bancorp Of North Carolina Inc 13G/A 7.7% 6mo
Fort Baker Capital Management LP PMTR Perimeter Acquisition Corp. I 13G 6.3% 6mo
Nantahala Capital Management, LLC GOGO Gogo Inc. 13G/A 6.59% 6mo
PLATINUM EQUITY, LLC INGM Ingram Micro Holding Corp 13G/A 85.1% 6mo
VIKING GLOBAL INVESTORS LP LAB Standard Biotools Inc. 13G/A 15% 6mo
Alyeska Investment Group, L.P. CRML Critical Metals Corp. 13G/A 8.07% 6mo
RTW INVESTMENTS, LP CADL Candel Therapeutics, Inc. 13G 8.8% 6mo
Newtyn Management, LLC PAR Par Technology Corp 13G 6.6% 6mo
ATW Growth Opportunities SPV, LLC WKHS Workhorse Group Inc. 13G/A 5% 6mo
ARMISTICE CAPITAL, LLC ESLA Estrella Immunopharma, Inc. 13G 9.99% 6mo
ARMISTICE CAPITAL, LLC CTOR Citius Oncology, Inc. 13G/A 9.99% 6mo
WELLINGTON MANAGEMENT GROUP LLP MEOH Methanex Corp 13G 5.8% 6mo
Caracola Ventures Corp NUAI New ERA Energy & Digital, Inc. 13G/A 8.6% 6mo
MMCAP International Inc. SPC WSTRF Western Uranium & Vanadium Corp. 13G/A 5% 6mo
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD EMF Templeton Emerging Markets Fund 13G/A 23.7% 6mo
Logos Global Management LP AVTX Avalo Therapeutics, Inc. 13G/A 3.2% 6mo
T. Rowe Price Investment Management, Inc. STVN Stevanato Group S.p.A. 13G/A 6.5% 6mo